Technical Comparison
Climb Bio, Inc. - Common Stock vs NVIDIA Corporation - Common Stock
Real-time financial comparison matrix between CLYM and NVDA.
Primary Asset
CLY
Climb Bio, Inc. - Common Stock
Market Rank #1001081Live Price$15.52
Market Capitalization$891M
24h Change+6.37%
Circulating Supply57M CLYM
Comparison Asset
NVD
NVIDIA Corporation - Common Stock
Market Rank #101Live Price$230.36
Market Capitalization$5.6T
24h Change+0.84%
Circulating Supply24B NVDA
Market Metric Matrix
| Comparison Metric | CLYM Value | NVDA Value | Dominant Asset |
|---|---|---|---|
| Market Cap Rank | #1001081 | #101 | NVIDIA Corporation - Common Stock |
| Unit Price Valuation | $15.52 | $230.36 | NVIDIA Corporation - Common Stock |
| Total Liquid Cap | $891M | $5.6T | NVIDIA Corporation - Common Stock |
Frequently Asked Questions
Is Climb Bio, Inc. - Common Stock bigger than NVIDIA Corporation - Common Stock?
Climb Bio, Inc. - Common Stock has a market cap of $891M, while NVIDIA Corporation - Common Stock sits at $5.6T. Therefore, NVIDIA Corporation - Common Stock is currently the larger financial asset by market capitalization.
What is the price ratio between Climb Bio, Inc. - Common Stock and NVIDIA Corporation - Common Stock?
Currently, 1 CLYM is worth 0.07 NVDA.